22470868

Ganie MA

2012

Pattern of urinary albumin excretion in normotensive young and adolescent Indian women with polycystic ovary syndrome.

22471422

Billhult A

2012

Acupuncture with manual and low frequency electrical stimulation as experienced by women with polycystic ovary syndrome: a qualitative study.

22473394

Cinar N

2012

Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study.

22473412

Batista JG

2012

Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study.

22475072

Kulshreshtha B

2012

Effect of metformin and spironolactone therapy on OGTT in patients with polycystic ovarian syndrome - a retrospective analysis.

22475130

Johnstone EB

2012

Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population.

22480428

V?el?k J

2012

T2D risk haplotypes of the TCF7L2 gene in the Czech population sample: the association with free fatty acids composition.

22480516

Figueroa F

2012

Macrophage secretions modulate the steroidogenesis of polycystic ovary in rats: effect of testosterone on macrophage pro-inflammatory cytokines.

22481889

Amador RR

2012

Metformin (dimethyl-biguanide) induced DNA damage in mammalian cells.

22486287

Dlouh? D

2012

[FTO gene and his role in genetic determination of obesity].

22487725

Usta T

2012

Is the measurement of anti-M?llerian hormone essential?

22488491

Motta EL

2012

[Use of insulin sensitizers in the treatment of infertility in patients with polycystic ovary syndrome (POS)].

22488497

Pontes AG

2012

[The importance of oral glucose tolerance test in diagnosis of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome].

22493025

Moran LJ

2012

Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome.

22495105

Thomopoulos C

2013

Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review.

22497305

Liang SJ

2012

Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome.

22498014

Burchall G

2011

Hemostatic abnormalities and relationships to metabolic and hormonal status in polycystic ovarian syndrome.

22498245

Stears A

2012

Metabolic insights from extreme human insulin resistance phenotypes.

22499345

Li T

2012

Identification of YAP1 as a novel susceptibility gene for polycystic ovary syndrome.

22500381

Lian F

2012

[Effects of Shen invigorating and Chong-channel regulating method on anti-M?llerian hormone and oocyte quality in polycystic ovarian syndrome patients].

22500393

Ma HX

2012

[Effects of Yangling Zhongyu Decoction on the secretion of ovarian granule cells in polycystic ovarian syndrome rat model].

22500844

Firouzabadi Rd

2012

Therapeutic effects of calcium & vitamin D supplementation in women with PCOS.

22503417

Reyes-Mu?oz E

2012

The risk of gestational diabetes mellitus among Mexican women with a history of infertility and polycystic ovary syndrome.

22504079

Eriksen MB

2012

Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis.

22507264

Nidhi R

2012

Effect of a yoga program on glucose metabolism and blood lipid levels in adolescent girls with polycystic ovary syndrome.

22508577

Cao S

2012

Comparative proteomic analysis of proteins involved in oocyte meiotic maturation in mice.

22508703

Palomba S

2012

Decidual endovascular trophoblast invasion in women with polycystic ovary syndrome: an experimental case-control study.

22509734

Cinar N

2013

Ethinyl estradiol-drospirenone vs ethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome.

22509751

?z?aka ?

2012

Is there an interaction between polycystic ovary syndrome and gingival inflammation?

22510229

Gomes VA

2012

Oral contraceptive containing chlormadinone acetate and ethinylestradiol reduces plasma concentrations of matrix metalloproteinase-2 in women with polycystic ovary syndrome.

22512829

Mousiolis A

2012

Polycystic ovary syndrome: double click and right check. What do patients learn from the Internet about PCOS?

22516925

Siebert TI

2012

Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis.

22518124

Zhong YP

2012

Comparison of Endocrine Profile and In Vitro Fertilization Outcome in Patients with PCOS, Ovulatory PCO, or Normal Ovaries.

22519483

Bell A

2012

Evidence of biochemical hyperandrogenism in women: the limitations of serum testosterone quantitation.

22521026

B?rtolo M

2011

[Fowler's Syndrome: diagnostic and therapeutic challenge].

22521457

Siristatidis C

2012

Ovulation induction in women with polycystic ovarian syndrome: still steps to take.

22522778

Celik O

2012

Effects of metformin plus rosuvastatin on hyperandrogenism in polycystic ovary syndrome patients with hyperlipidemia and impaired glucose tolerance.

22523112

Ruan Y

2012

Association of IRS-1 and IRS-2 genes polymorphisms with polycystic ovary syndrome: a meta-analysis.

22523607

Dessinioti C

2009

Congenital adrenal hyperplasia.

22523872

K???? A

2012

Does assisted reproductive technology itself or polycystic ovary syndrome as a cause of infertility have any effect on first trimester serum screening results?

22525898

Casper RF

2012

Detrimental effect of induced or spontaneous menses before ovulation induction on pregnancy outcome in patients with polycystic ovary syndrome.

22525900

Diamond MP

2012

Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome.

22527903

He J

2012

A meta-analysis on the association between PPAR-? Pro12Ala polymorphism and polycystic ovary syndrome.

22534323

Shang K

2012

Endometrial abnormality in women with polycystic ovary syndrome.

22538004

Velazquez MA

2012

In vivo oocyte IGF-1 priming increases inner cell mass proliferation of in vitro-formed bovine blastocysts.

22540635

Salehpour S

2012

N-Acetylcysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome.

22541319

Rezvanfar MA

2012

Molecular mechanisms of a novel selenium-based complementary medicine which confers protection against hyperandrogenism-induced polycystic ovary.

22541936

Rosenfield RL

2012

Antim?llerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries.

22543078

Tremellen K

2012

Dysbiosis of Gut Microbiota (DOGMA)--a novel theory for the development of Polycystic Ovarian Syndrome.

22546001

Liu N

2012

Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome.

22546954

Zhuo G

2012

Analysis of mitochondrial DNA sequence variants in patients with polycystic ovary syndrome.

22547260

Diamanti-Kandarakis E

2012

Reproductive endocrinology: Infertility treatment in PCOS--is metformin in from the cold?

22547425

Welt CK

2012

Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry.

22548946

Messer C

2012

Pancreatic ?-cell dysfunction in polycystic ovary syndrome: the role of metformin.

22549343

Aydogdu A

2012

Women with polycystic ovary syndrome have increased plasma chitotriosidase activity: a pathophysiological link between inflammation and impaired insulin sensitivity?

22551817

Buvat J

2012

[Congress reports. Report on main podium presentations on women's sexual health to the 14th annual meeting of the European Society for Sexual Medicine (Milano, December 1-4, 2011)].

22552687

Thomson RL

2012

The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome.

22552733

Peng C

2012

Progesterone levels on the hCG day and outcomes in vitro fertilization in women with polycystic ovary syndrome.

22553983

Deligeoroglou E

2012

Mediators of chronic inflammation in polycystic ovarian syndrome.

22554175

Costello MF

2012

Evidence-based lifestyle and pharmacological management of infertility in women with polycystic ovary syndrome.

22554176

Costello MF

2012

Evidence-based management of infertility in women with polycystic ovary syndrome using surgery or assisted reproductive technology.

22556376

Ou XH

2012

Maternal insulin resistance causes oxidative stress and mitochondrial dysfunction in mouse oocytes.

22560062

Yava?oglu I

2012

Anti-Helicobacter pylori antibodies and polycystic ovary syndrome.

22560129

Krentz AJ

2012

Adipocytokine profiles in a putative novel postmenopausal polycystic ovary syndrome (PCOS) phenotype parallel those in premenopausal PCOS: the Rancho Bernardo Study.

22562700

Sechi A

2013

Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study.

22563547

Kim CH

2012

Effectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase compared with GnRH agonist long protocol in non-obese and obese patients with polycystic ovary syndrome undergoing IVF/ICSI.

22563801

Zayed A

2012

Subfertility in women with familial Mediterranean fever.

22563947

Kaya MG

2012

The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome.

22564702

Zhang H

2012

Association between the Pro12Ala polymorphism of PPAR-? gene and the polycystic ovary syndrome: a meta-analysis of case-control studies.

22565190

Schweighofer N

2012

Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.

22568358

Krepu?a K

2012

Selected neurologic disorders related to polycystic ovary syndrome.

22569241

Gonz?lez F

2012

Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women.

22569710

Haydardedeoglu B

2012

IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial.

22570795

Kuivasaari-Pirinen P

2012

Adverse Outcomes of IVF/ICSI Pregnancies Vary Depending on Aetiology of Infertility.

22571176

Trakakis E

2012

The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome.

22571227

Li J

2012

Differentiation of polycystic ovary syndrome-derived human embryonic stem cells into adipocytes and their glucose consumption.

22572996

Zhai J

2012

Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome.

22574574

Liao YJ

2012

[Considerations about study on the underlying mechanism of acu-moxibustion in the treatment of obesity type polycystic ovary syndrome by regulating adiponectin].

22574610

Fang QJ

2012

[The progress of polycystic ovarian syndrome treated by integrative medicine].

22574874

Thomson RL

2012

Vitamin D in the aetiology and management of polycystic ovary syndrome.

22575496

Norman RJ

2012

Does ovulation induction with follicle-stimulating hormone still have a future in polycystic ovary syndrome?

22575725

Dasgupta S

2012

Polymorphisms in the IRS-1 and PPAR-? genes and their association with polycystic ovary syndrome among South Indian women.

22576257

Dong Z

2012

Free testosterone level correlated with the metabolic abnormalities dependent on central obesity in women with polycystic ovary syndrome.

22576259

Mario FM

2012

Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance.

22576737

He H

2012

HOXA10 expression is decreased by testosterone in luteinized granulosa cells in vitro.

22577112

Abramovich D

2012

Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome.

22578028

Orvieto R

2012

Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue?

22578482

Rahmanpour H

2012

Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents.

22579050

Escobar-Morreale HF

2012

Iron metabolism and the polycystic ovary syndrome.

22579228

Vosnakis C

2012

Sibutramine administration decreases serum anti-M?llerian hormone (AMH) levels in women with polycystic ovary syndrome.

22583042

Holm NS

2012

The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism.

22583189

Celik C

2012

Elevated circulating levels of YKL-40 are a marker of abnormal glucose tolerance in women with polycystic ovary syndrome.

22583337

Pelusi C

2013

No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours.

22584727

Guo X

2012

Insulin clearance: confirmation as a highly heritable trait, and genome-wide linkage analysis.

22587479

Isabella R

2012

Does ovary need D-chiro-inositol?

22589237

Berstein LM

2012

Metformin in obesity, cancer and aging: addressing controversies.

22592687

Tang T

2012

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

22594862

Shannon M

2012

Polycystic ovary syndrome: a common but often unrecognized condition.

22605534

Alc?zar JL

2012

Ovarian stromal vessels assessed by spatiotemporal image correlation-high definition flow in women with polycystic ovary syndrome: a case-control study.

22607465

Alanbay I

2012

Neopterin: a promising marker for the inflammation in polycystic ovary syndrome.